Enterprise Value to EBITDA Multiple ratio Analysis of Akero Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-8.99
Period Ending - Dec-22
Very Poor EV to EBITDA
-6.25
Growth
-43.86 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-7.39
EV to EBITDA Analysis of Akero Therapeutics Inc
| EV to EBITDA Ratio of AKRO drastically fell by -43.86 % this year. |
| EV to EBITDA Ratio with value of -6.25 was highest in Year Dec-22 in last Five Years. |
| EV to EBITDA Ratio with value of -8.99 was lowest in Year Dec-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -8.99 is lower than Average EV to EBITDA of -7.20 in last five years. |
Other EV to EBITDA Related Info of AKRO that may interest you.
Akero Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| AKRO | 23.98 | 24.62 | 2.60 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Akero Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -8.99 | -6.25 | -6.80 | -7.17 | -6.78 | -0.912 | -138.03 |
| Change | -43.86 % | 8.13 % | 5.14 % | -5.72 % | -643.11 % | 99.34 % |
FY Chart of Enterprise Value to EBITDA Multiple of Akero Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)